NCT05884463 is a NA clinical trial of 18F-FAPI in 18F-FAPI, sponsored by Zhejiang University.

Who is sponsoring NCT05884463?

NCT05884463 is sponsored by Zhejiang University.

What drugs are being tested in NCT05884463?

Interventions in NCT05884463: 18F-FAPI, 18F-FDG.

What condition does NCT05884463 study?

NCT05884463 studies 18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma, Diagnosis, Staging.

Is NCT05884463 still recruiting?

NCT05884463 is currently completed. Last updated 1 June 2023.

Last reviewed 2023-06-01 · How we verify

NCT05884463

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Completed NA Last updated 1 June 2023

What this trial tests

NA trial testing 18F-FAPI in 18F-FAPI in 62 participants. Completed in 28 February 2023.

Timeline

1 April 2021

Primary endpoint
28 February 2023

28 February 2023

Quick facts

Lead sponsor	Zhejiang University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	62
Start date	1 April 2021
Primary completion	28 February 2023
Estimated completion	28 February 2023
Sites	1 location across China

Drugs / interventions tested

18F-FAPI — full drug profile →
18F-FDG — full drug profile →

Conditions studied

18F-FAPI — all drugs for 18F-FAPI →
18F-FDG — all drugs for 18F-FDG →
Pancreas Adenocarcinoma — all drugs for Pancreas Adenocarcinoma →
Diagnosis — all drugs for Diagnosis →

Sponsor

Zhejiang University

Who can join

Adults 18 to 80, any sex, with 18F-FAPI or 18F-FDG. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore the potential efficacy of 18F-FAPI-04 PET/CT for PDAC tumour staging and compare the results with those obtained using 18F-FDG PET/CT.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma.
Li X, Lu N, Lin L, Chen Y, et al · · 2024 · cited 26× · PMID 38176719 · DOI 10.2967/jnumed.123.266283
Clinical Utility of 18Fluorine-Fibroblast Activation Protein Inhibitor-04 Positron Emission Tomography/Computed Tomography in the Evaluation of Pancreatic Ductal Adenocarcinoma: Comparison With 18Fluorine-Fluorodeoxyglucose Positron E
Lin L, Wang G, Zhang Y, Wang G, et al · · 2025 · cited 2× · PMID 40066225 · DOI 10.1002/mco2.70136
Prognostic Value of Coronary Angiography-Derived Index of Microvascular Resistance in Patients With Hypertrophic Cardiomyopathy.
Zhang Y, Ji R, Lei S, Pan J, et al · · 2025 · cited 1× · PMID 40717902 · DOI 10.1002/mco2.70289

Verify or expand the search:

Other trials of 18F-FAPI

Trials testing the same drug.

NCT05810324 — 18F-FAPI PET/CT in Patients With Various Types of Cancer · NA · unknown
NCT05262647 — 18F-FAPI PET in the Diagnosis of Liver Fibrosis · unknown

Other recruiting trials for 18F-FAPI

Currently open trials in the same condition.

NCT07107919 — Multimodal Imaging Assessment of Chronic Kidney Disease Patients at Different Stages From a Cardio-Renal Interaction Per · recruiting

Other Zhejiang University trials

Trials by the same sponsor.

NCT07487402 — Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurr · EARLY_PHASE1 · not yet recruiting
NCT07480044 — A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly · NA · not yet recruiting
NCT07467005 — Video Double-Lumen Tube for Secondary Pulmonary Resection · NA · not yet recruiting
NCT07429461 — Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia · EARLY_PHASE1 · recruiting
NCT07240766 — HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05884463 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zhejiang University
Last refreshed: 1 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05884463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing